Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
2021 · Nature Communications · 80 citations
https://doi.org/10.1038/s41467-021-23752-2
V
Veronika Ecker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
599
Citations
10
h-index
10
i10-index
Veronika Ecker is an academic researcher from Munich Leukemia Laboratory (Germany). The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Advanced Breast Cancer Therapies & Pancreatic and Hepatic Oncology Research. The author has an h-index of 10, co-authored 32 publications.
ORCID: 0000-0001-6477-0715Papers by this author
worksUtilizing in vitro drug release assays to predict in vivo drug retention in micelles
2022 · International Journal of Pharmaceutics · 39 citations
https://doi.org/10.1016/j.ijpharm.2022.121638
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression
2023 · Cell Reports · 20 citations
https://doi.org/10.1016/j.celrep.2023.113017
Integrating Inline Quality Control at the MRI Scanner: Global and Local Assessment of Motion Artifacts Using Deep Learning
2025 · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 0 citations
https://doi.org/10.58530/2025/4616
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat